Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | TQB3804 |
Synonyms | |
Therapy Description |
TQB3804 (EGFR-IN-7) is a 4th generation EGFR inhibitor that demonstrates activity against EGFR TKI resistance mutations, and may lead to anti-tumor effect (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1320). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TQB3804 | TQB 3804|TQB-3804|EGFR-IN-7 | EGFR Inhibitor (Pan) 61 | TQB3804 (EGFR-IN-7) is a 4th generation EGFR inhibitor that demonstrates activity against EGFR TKI resistance mutations, and may lead to anti-tumor effect (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1320). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|